Evidence map›Paper›PMID 21210868›Full record

ArticleMolecular microbiology2011

Tandem use of selenocysteine: adaptation of a selenoprotein glutaredoxin for reduction of selenoprotein methionine sulfoxide reductase.

Moon-Jung Kim, Byung Cheon Lee, Jaeho Jeong, Kong-Joo Lee, Kwang Yeon Hwang, Vadim N Gladyshev, Hwa-Young Kim

Open access · bronzeAbstract read
In one paragraph

Article in Molecular microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Selenium utilization in thioredoxin and catalytic advantage provided by selenocysteine.Biochemical and biophysical research communications · 2015
    Article
  6. Article
  7. Article
  8. Review
  9. Evaluation of a dithiocarbamate derivative as an inhibitor of human glutaredoxin-1.Journal of enzyme inhibition and medicinal chemistry · 2013
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Moon-Jung KimDepartment of Biochemistry and Molecular Biology, Yeungnam University College of Medicine, Daegu 705-717, Korea.
Byung Cheon Lee
Jaeho Jeong
Kong-Joo Lee
Kwang Yeon Hwang
Vadim N Gladyshev
Hwa-Young Kim
Ewha Womans University · KRHarvard University · USKorea University · KRUniversity of Nebraska–Lincoln · USYeungnam University · KRYeungnam University College

Funding

Methionine sulfoxide reduction, selenium and agingR01AG021518 · NIA · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2003 to 2018
$5.0M
IDENTITY OF TERMINATOR AND SELENOCYSTEINE UGA CODONSR01GM061603 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2000 to 2016
$4.0M
NIA NIH HHS AG021518NIA NIH HHS R01 AG021518NIGMS NIH HHS GM061603NIGMS NIH HHS R01 GM061603
6 · The paper itself

Abstract

Several engineered selenocysteine (Sec)-containing glutaredoxins (Grxs) and their enzymatic properties have been reported, but natural selenoprotein Grxs have not been previously characterized. We expressed a bacterial selenoprotein Grx from Clostridium sp. (also known as Alkaliphilus oremlandii) OhILAs in Escherichia coli and characterized this selenoenzyme and its natural Cys homologues in Clostridium and E. coli. The selenoprotein Grx had a 200-fold higher activity than its Sec-to-Cys mutant form, suggesting that Sec is essential for catalysis by this thiol-disulfide oxidoreductase. Kinetic analysis also showed that the selenoprotein Grx had a 10-fold lower K(m) than Cys homologues. Interestingly, this selenoenzyme efficiently reduced a Clostridium selenoprotein methionine sulfoxide reductase A (MsrA), suggesting that it is the natural reductant for the protein that is not reducible by thioredoxin, a common reductant for Cys-containing MsrAs. We also found that the selenoprotein Grx could not efficiently reduce a Cys version of Clostridium MsrA, whereas natural Clostridium and E. coli Cys-containing Grxs, which efficiently reduce Cys-containing MsrAs, poorly acted on the selenoprotein MsrA. This specificity for MsrA reduction could explain why Sec is utilized in Clostridium Grx and more generally provides a novel example of the use of Sec in biological systems.

Indexed as

Amino Acid SequenceBacterial ProteinsClostridiumEscherichia coliGlutaredoxinsKineticsMethionine Sulfoxide ReductasesMolecular Sequence DataOxidation-ReductionProtein EngineeringSelenocysteineSelenoproteinsSequence AlignmentBacterial ProteinsGlutaredoxinsmethionine sulfoxide reductaseMethionine Sulfoxide ReductasesSelenocysteineSelenoproteins

Identifiers

PMID21210868
PMCPMC3062254
OpenAlexW2113670995

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.